Read + Share
Amedeo Smart
Independent Medical Education
Jia X, Wang K, Zhuo Q, Zhao Z, et al. PARP Inhibitor for Neoadjuvant Therapy in HER2-Negative Breast Cancer: A Systematic Review and Meta-Analysis of Efficacy and Safety. Clin Breast Cancer 2024 Mar 2:S1526-8209(24)00059.PMID: 38580572
Email
LinkedIn
Facebook
Twitter
Privacy Policy